Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Venous thromboangiitis associated with regional enteritis.

S Motte1, F Flamme, M Depierreux

  • 1Department of Vascular Surgery, Erasme University Hospital, Brussels, Belgium.

International Angiology : a Journal of the International Union of Angiology
|July 1, 1992
PubMed
Summary

Patients with Crohn's disease (a chronic inflammatory bowel disease) face high mortality from thromboembolic events. This case suggests a vascular immune reaction may cause these thrombotic complications, even with subclinical gastrointestinal disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term antithrombotic therapy practices in adult patients with short bowel syndrome following acute mesenteric ischemia: An international case-based survey.

Clinical nutrition ESPEN·2025
Same author

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Acta gastro-enterologica Belgica·2024
Same author

Post-colonoscopy appendicitis: a thought-provoking unresolved entity.

Acta gastro-enterologica Belgica·2024
Same author

Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut-Brain Interaction.

Neurogastroenterology and motility·2024
Same author

Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut-Brain Interaction.

Clinical nutrition (Edinburgh, Scotland)·2024
Same author

Polypoid colon mucosa in a leukemia patient.

Acta gastro-enterologica Belgica·2022

Area of Science:

  • Gastroenterology
  • Hematology
  • Immunology

Background:

  • Thromboembolic complications are a serious concern in Crohn's disease patients, often leading to high mortality.
  • The underlying mechanisms driving thrombogenesis in Crohn's disease remain incompletely understood.
  • Emerging evidence suggests Crohn's disease may involve a chronic vasculitis impacting the gastrointestinal tract.

Observation:

  • This report details an unusual case of recurrent venous thrombosis in a patient with regional enteritis (Crohn's disease).
  • The patient experienced significant venous thrombotic events while the gastrointestinal manifestations of Crohn's disease were clinically silent for over four years.
  • Morphological evidence indicated an angiitic process contributing to the extradigestive thrombotic complications.

Findings:

Related Experiment Videos

  • The case provides morphological support for an angiitic (vascular inflammation) process as a cause of extradigestive thrombosis in Crohn's disease.
  • It highlights that severe thrombotic events can occur in the context of subclinical gastrointestinal disease.
  • An imbalance in the cellular hemostatic pathway is hypothesized to mediate these thrombotic events.

Implications:

  • This case underscores the potential link between the vascular immune response in Crohn's disease and systemic thrombotic risks.
  • It suggests that patients with Crohn's disease, even with quiescent gastrointestinal symptoms, may require vigilant monitoring for thromboembolic complications.
  • Further research into the vascular immune mechanisms in Crohn's disease is warranted to improve patient outcomes and develop targeted therapies.